PMID: 7023233Jan 1, 1981Paper

Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids

American Journal of Hematology
K DoneyE D Thomas

Abstract

This prospective randomized trial compared the effect of antihuman thymocyte globulin (ATG) versus corticosteroids as treatment of graft-versus-host disease (GVHD) in recipients of HLA-identical allogeneic bone marrow transplants. Patients undergoing transplantation as therapy for either hematologic malignancies or aplastic anemia were given methotrexate as postgrafting immunosuppression. Patients who nevertheless developed acute GVHD of moderate severity were randomized to receive either corticosteroid therapy or ATG therapy. Thirty-seven patients were randomized: 20 patients received corticosteroids, and 17 received ATG. Both ATG and corticosteroids were in general well tolerated, although all patients receiving ATG developed fever and chills. Both treatment modalities were associated with a mild decrease in severity of GVHD after therapy. There was, however, no significant difference between treatment groups, whether assessed by improvement in specific organ involvement, improvement in the overall grade of GVHD, need for additional therapy for acute GVHD, or the proportion of patients who developed chronic GVHD. Infectious complications and survival were also not different between treatment groups. Thus, corticosteroids were...Continue Reading

References

Dec 1, 1978·Annals of Internal Medicine·C D BucknerE D Thomas
Apr 17, 1975·The New England Journal of Medicine·E ThomasC D Buckner
Sep 13, 1979·The New England Journal of Medicine·E D ThomasP L Weiden
May 11, 1978·The New England Journal of Medicine·R A CliftC D Buckner

❮ Previous
Next ❯

Citations

May 18, 2005·Clinics in Dermatology·Erich Vargas-DíezJesus Fernández-Herrera
Mar 29, 2001·Experimental Hematology·H GokerN J Chao
Oct 1, 1983·Clinics in Haematology·R Storb, G W Santos
Oct 1, 1983·Clinics in Haematology·K M Sullivan, R Parkman
Feb 1, 1986·Clinics in Haematology·G L Phillips, D E Reece
Apr 20, 2001·Critical Reviews in Oncology/hematology·N BasaraA A Fauser
Jun 8, 2001·Clinical Transplantation·M RembergerO Ringdén
Oct 6, 2010·Bone Marrow Transplantation·M SchlaakH K Al-Ali
Mar 25, 1982·The New England Journal of Medicine·B M CamittaE D Thomas
Dec 1, 1987·Australian Paediatric Journal·M R Vowels
Mar 2, 1985·British Medical Journal·A M Denman
Apr 4, 2002·Drugs·David A Jacobsohn, Georgia B Vogelsang
Jan 25, 2005·American Journal of Clinical Dermatology·Pablo F PeñasAmaro García-Diez
Sep 2, 2011·Haematologica·Carmen Martínez, Alvaro Urbano-Ispízua
Dec 3, 2005·Hematology·Steve ScaglionePatrick Stiff
Nov 1, 1993·Cancer Immunology, Immunotherapy : CII·U N Verma, A Mazumder
Apr 1, 1995·The American Journal of Medicine·J Somani, R A Larson
Jan 1, 1983·Critical Reviews in Clinical Laboratory Sciences·P L Weiden
Apr 28, 2000·Leukemia & Lymphoma·H T GreinixR M Knobler
Aug 13, 2008·Expert Opinion on Investigational Drugs·María Díez-CampeloJosé A Pérez Simón
Jan 1, 1984·Cancer Investigation·K M Sullivan, R Storb
Apr 24, 2007·Best Practice & Research. Clinical Haematology·Ernst Holler
Apr 11, 2007·The British Journal of Dermatology·J M L WhiteG J Mufti
Jan 1, 1986·Current Problems in Cancer·M M Bortin
Jan 1, 1986·International Journal of Cell Cloning·K M Sullivan
Dec 1, 1987·British Journal of Haematology·R P GaleJ H Kersey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.